[{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CL06-12 Vaccines (oncolytic and prophylactic),,"},{"Key":"Keywords","Value":"Oncolytic virus,T cell,Immune response,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>O. Lyudovyk<\/b><sup>1<\/sup>, B. Burman<sup>2<\/sup>, N. Ceglia<sup>3<\/sup>, B. Greenbaum<sup>3<\/sup>, Y. Elhanati<sup>3<\/sup>, D. Zamarin<sup>4<\/sup>; <br\/><sup>1<\/sup>Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, <sup>2<\/sup>AstraZeneca, Memorial Sloan Kettering Cancer Center, New York, NY, <sup>3<\/sup>Memorial Sloan Kettering Cancer Center, New York, NY, <sup>4<\/sup>Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY","CSlideId":"","ControlKey":"50137140-6aeb-425a-be89-b21121fb219f","ControlNumber":"10596","DisclosureBlock":"<b>&nbsp;O. Lyudovyk, <\/b> <br><b>Pfizer<\/b> Stock. <br><b>Moderna<\/b> Stock. <br><b>AstraZeneca<\/b> Stock. <br><b>B. Burman, <\/b> <br><b>AstraZeneca<\/b> Employment.<br><b>N. Ceglia, <\/b> None.&nbsp;<br><b>B. Greenbaum, <\/b> <br><b>Merck<\/b> Other, speaking engagements. <br><b>Bristol Meyers Squibb<\/b> Grant\/Contract, Other, speaking engagements. <br><b>Chugai Pharmaceutical<\/b> Other, speaking engagements. <br><b>PMV Pharma<\/b> Other, Consulting services. <br><b>DarwinHealth<\/b> Other, Consulting services. <br><b>ROME Therapeutics<\/b> Other, Co-founder, Consulting services.<br><b>Y. Elhanati, <\/b> None.&nbsp;<br><b>D. Zamarin, <\/b> <br><b>Takeda<\/b> Other, Consulting or Other Professional Services. <br><b>Bioinvent<\/b> Other, Consulting or Other Professional Services. <br><b>Xencor<\/b> Other, Consulting or Other Professional Services. <br><b>Synthekine<\/b> Other, Consulting or Other Professional Services. <br><b>Calidi Biotherapeutics<\/b> Stock Option, Other, Consulting or Other Professional Services. <br><b>BioCanRX<\/b> Other, Consulting or Other Professional Services. <br><b>Kalivir<\/b> Other, Consulting or Other Professional Services. <br><b>Genentech<\/b> Other, Consulting or Other Professional Services. <br><b>Glaxosmithkline<\/b> Other, Consulting or Other Professional Services. <br><b>Astrazeneca<\/b> Other, Consulting or Other Professional Services. <br><b>Related Sciences<\/b> Other, Consulting or Other Professional Services. <br><b>Immunos<\/b> Stock Option, Other, Consulting or Other Professional Services. <br><b>Miltenyi<\/b> Other, Consulting or Other Professional Services. <br><b>Memgen<\/b> Other, Consulting or Other Professional Services. <br><b>Accurius Therapeutics, Inc.<\/b> Fiduciary Officer, Other Business Ownership.","End":"4\/10\/2024 12:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"10428","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"1","PosterboardNumber":"1","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB400","PresenterBiography":null,"PresenterDisplayName":"Olga Lyudovyk, MA;MBA","PresenterKey":"de403be2-494f-4b9a-a09b-07056e680888","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB400. Evolution of anti-viral and anti-tumor immunity in tumors in response to oncolytic virus therapy","SearchResultFooter":"","SearchResultHeader":"Apr 10 2024  9:00AM","SessionId":"596","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Clinical Research 3","ShowChatLink":"false","Start":"4\/10\/2024 9:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Evolution of anti-viral and anti-tumor immunity in tumors in response to oncolytic virus therapy","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CL06-12 Vaccines (oncolytic and prophylactic),,"},{"Key":"Keywords","Value":"Neoantigens,Cancer vaccine,Vaccinia virus,Head and neck cancers,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"A. Lalanne<sup>1<\/sup>, C. Jamet<sup>1<\/sup>, J.-P. Delord<sup>2<\/sup>, C. Ottensmeier<sup>3<\/sup>, C. Le Tourneau<sup>1<\/sup>, A. Tavernaro<sup>4<\/sup>, G. Lacoste<sup>4<\/sup>, B. Bastien<sup>4<\/sup>, M. Brandely<sup>4<\/sup>, B. Grellier<sup>4<\/sup>, E. Quemeneur<sup>4<\/sup>, Y. Yamashita<sup>5<\/sup>, O. Kousuke<sup>5<\/sup>, N. Yamagata<sup>5<\/sup>, Y. Tanaka<sup>5<\/sup>, K. Onoguchi<sup>5<\/sup>, I. Pait<sup>5<\/sup>, B. Malone<sup>6<\/sup>, O. Baker<sup>7<\/sup>, P. Brattas<sup>6<\/sup>, M. Gheorghe<sup>6<\/sup>, R. Stratford<sup>6<\/sup>, T. Clancy<sup>6<\/sup>, K. Bendjama<sup>6<\/sup>, <b>O. Lantz<\/b><sup>1<\/sup>; <br\/><sup>1<\/sup>Institut Curie, Paris, France, <sup>2<\/sup>IUCT Oncopole, Toulouse, France, <sup>3<\/sup>The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, United Kingdom, <sup>4<\/sup>Transgene SA, Illkirch-Graffenstaden, France, <sup>5<\/sup>NEC Corporation, Tokyo, Japan, <sup>6<\/sup>NEC Oncoimmunity AS, Oslo, Norway, <sup>7<\/sup>NEC Laboratories Europe GmbH, Heidelberg, Germany","CSlideId":"","ControlKey":"a471e114-8591-4444-8164-d64c275be859","ControlNumber":"10614","DisclosureBlock":"&nbsp;<b>A. Lalanne, <\/b> None..<br><b>C. Jamet, <\/b> None.&nbsp;<br><b>J. Delord, <\/b> <br><b>BMS<\/b> Grant\/Contract, Other, Advisory Board. <br><b>MSD<\/b> Grant\/Contract, Other, Advisory Board. <br><b>Genentech<\/b> Grant\/Contract. <br><b>Pierre Fabre<\/b> Other, Advisory Board. <br><b>Roche<\/b> Other, Advisory Board. <br><b>AstraZeneca<\/b> Grant\/Contract. <br><b>Transgene<\/b> Grant\/Contract. <br><b>C. Ottensmeier, <\/b> <br><b>Transgene<\/b> Grant\/Contract. <br><b>C. Le Tourneau, <\/b> <br><b>MSD<\/b> Other, Advisory Board. <br><b>BMS<\/b> Other, Advisory Board. <br><b>Merck KGaa<\/b> Other, Advisory Board. <br><b>Roche<\/b> Other, Advisory Board. <br><b>Seattle Genetics<\/b> Other, Advisory Board. <br><b>Cellgene<\/b> Other, Advisory Board. <br><b>Rakuten<\/b> Other, Advisory Board. <br><b>ALX Oncology<\/b> Other, Advisory Board. <br><b>AstraZeneca<\/b> Other, Advisory Board. <br><b>A. Tavernaro, <\/b> <br><b>Transgene SA<\/b> Employment. <br><b>G. Lacoste, <\/b> <br><b>Transgene SA<\/b> Employment. <br><b>B. Bastien, <\/b> <br><b>Transgene SA<\/b> Employment. <br><b>M. Brandely, <\/b> <br><b>Transgene SA<\/b> Employment. <br><b>B. Grellier, <\/b> <br><b>Transgene SA<\/b> Employment. <br><b>E. Quemeneur, <\/b> <br><b>Transgene SA<\/b> Employment. <br><b>Y. Yamashita, <\/b> <br><b>NEC Corporation<\/b> Employment. <br><b>O. Kousuke, <\/b> <br><b>NEC Corporation<\/b> Employment. <br><b>N. Yamagata, <\/b> <br><b>NEC Corporation<\/b> Employment. <br><b>Y. Tanaka, <\/b> <br><b>NEC Corporation<\/b> Employment. <br><b>K. Onoguchi, <\/b> <br><b>NEC Corporation<\/b> Employment. <br><b>I. Pait, <\/b> <br><b>NEC Corporation<\/b> Employment. <br><b>B. Malone, <\/b> <br><b>NEC Oncoimmunity AS<\/b> Employment. <br><b>O. Baker, <\/b> <br><b>NEC Laboratories Europe GmbH<\/b> Employment. <br><b>P. Brattas, <\/b> <br><b>NEC Oncoimmunity AS<\/b> Employment. <br><b>M. Gheorghe, <\/b> <br><b>NEC Oncoimmunity AS<\/b> Employment. <br><b>R. Stratford, <\/b> <br><b>NEC Oncoimmunity AS<\/b> Employment. <br><b>T. Clancy, <\/b> <br><b>NEC Oncoimmunity AS<\/b> Employment. <br><b>K. Bendjama, <\/b> <br><b>NEC Oncoimmunity AS<\/b> Employment. <br><b>O. Lantz, <\/b> <br><b>Biommunex<\/b> Independent Contractor, Grant\/Contract. <br><b>Cereus<\/b> Stock, Grant\/Contract. <br><b>Immunocore<\/b> Grant\/Contract. <br><b>Transgene<\/b> Grant\/Contract.","End":"4\/10\/2024 12:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"10429","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"2","PosterboardNumber":"2","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB401","PresenterBiography":null,"PresenterDisplayName":"Olivier Lantz","PresenterKey":"3b6e2287-bc4d-46b3-adbb-b5b567191168","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB401. Personalized vaccine TG4050 induces polyepitopic immune responses against private neoantigens in resected HPV negative head and neck cancers","SearchResultFooter":"","SearchResultHeader":"Apr 10 2024  9:00AM","SessionId":"596","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Clinical Research 3","ShowChatLink":"false","Start":"4\/10\/2024 9:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Personalized vaccine TG4050 induces polyepitopic immune responses against private neoantigens in resected HPV negative head and neck cancers","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CL07-02 Childhood cancer drug development,,"},{"Key":"Keywords","Value":"Pediatric cancers,Preclinical testing,Antibody-drug conjugate (ADC),,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>R. Gorlick<\/b><sup>1<\/sup>, J. Gill<sup>1<\/sup>, W. Zhang<sup>1<\/sup>, Y. Mosse<sup>2<\/sup>, J. Maris<sup>2<\/sup>, D. Groff<sup>2<\/sup>, M. Smith<sup>3<\/sup>, B. Teicher<sup>3<\/sup>, S. Neuhauser<sup>4<\/sup>, T. Stearns<sup>4<\/sup>, V. Philip<sup>4<\/sup>, E. Jocoy<sup>4<\/sup>, J. Chuang<sup>4<\/sup>, C. J. Bult<sup>4<\/sup>, J. Hasegawa<sup>5<\/sup>, X. Qian<sup>6<\/sup>, P. Houghton<sup>7<\/sup>, R. Kurmasheva<sup>7<\/sup>; <br\/><sup>1<\/sup>The University of Texas MD Anderson Cancer Center, Houston, TX, <sup>2<\/sup>Children's Hospital of Philadelphia, Philadelphia, PA, <sup>3<\/sup>National Cancer Institute, Bethesda, MD, <sup>4<\/sup>The Jackson Laboratory, Bar Harbor, ME, <sup>5<\/sup>Daiichi-Sankyo Co., Ltd., Tokyo, Japan, <sup>6<\/sup>Daiichi-Sankyo Co., Ltd., Basking Ridge, NJ, <sup>7<\/sup>UT Health San Antonio, San Antonio, TX","CSlideId":"","ControlKey":"7bce1d8c-f737-4e9b-9fe5-0839d2ff6e8c","ControlNumber":"10553","DisclosureBlock":"&nbsp;<b>R. Gorlick, <\/b> None..<br><b>J. Gill, <\/b> None..<br><b>W. Zhang, <\/b> None..<br><b>Y. Mosse, <\/b> None..<br><b>J. Maris, <\/b> None..<br><b>D. Groff, <\/b> None..<br><b>M. Smith, <\/b> None..<br><b>B. Teicher, <\/b> None..<br><b>S. Neuhauser, <\/b> None..<br><b>T. Stearns, <\/b> None..<br><b>V. Philip, <\/b> None..<br><b>E. Jocoy, <\/b> None..<br><b>J. Chuang, <\/b> None..<br><b>C. J. Bult, <\/b> None.&nbsp;<br><b>J. Hasegawa, <\/b> <br><b>Daiichi-Sankyo Co., Ltd.<\/b> Employment. <br><b>X. Qian, <\/b> <br><b>Daiichi-Sankyo Co., Ltd.<\/b> Employment.<br><b>P. Houghton, <\/b> None..<br><b>R. Kurmasheva, <\/b> None.","End":"4\/10\/2024 12:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"10430","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"3","PosterboardNumber":"3","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB402","PresenterBiography":null,"PresenterDisplayName":"Richard Gorlick, MD","PresenterKey":"586c7044-005e-4316-a879-d4cfe3366762","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB402. In vivo efficacy of anti-B7-H3 antibody-drug conjugate (ADC) ifinatamab deruxtecan (I-DXd; DS-7300): An update from the Pediatric Preclinical In Vivo Testing (PIVOT) Program","SearchResultFooter":"","SearchResultHeader":"Apr 10 2024  9:00AM","SessionId":"596","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Clinical Research 3","ShowChatLink":"false","Start":"4\/10\/2024 9:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"In vivo efficacy of anti-B7-H3 antibody-drug conjugate (ADC) ifinatamab deruxtecan (I-DXd; DS-7300): An update from the Pediatric Preclinical In Vivo Testing (PIVOT) Program","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CL07-03 Immunotherapeutic approaches to pediatric cancer,,"},{"Key":"Keywords","Value":"Rhabdomyosarcoma,Antigen presentation,Epigenetics,Pediatric cancers,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>D. Milewski<\/b>, H.-C. Chou, V. Gangalapudi, M. Tian, Y. Kim, Y. Song, J. Wei, J. Khan; <br\/>National Cancer Inst. - Bethesda Campus, Bethesda, MD","CSlideId":"","ControlKey":"ab93c4bc-380e-485c-a578-9a4d2fc7e81b","ControlNumber":"10329","DisclosureBlock":"&nbsp;<b>D. Milewski, <\/b> None..<br><b>H. Chou, <\/b> None..<br><b>V. Gangalapudi, <\/b> None..<br><b>M. Tian, <\/b> None..<br><b>Y. Kim, <\/b> None..<br><b>Y. Song, <\/b> None..<br><b>J. Wei, <\/b> None..<br><b>J. Khan, <\/b> None.","End":"4\/10\/2024 12:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"10431","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"4","PosterboardNumber":"4","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB403","PresenterBiography":null,"PresenterDisplayName":"David Milewski, BA;PhD","PresenterKey":"e651817c-46e0-489b-b0d2-37bd80628a2a","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB403. Suppression of antigen presentation in pediatric rhabdomyosarcoma","SearchResultFooter":"","SearchResultHeader":"Apr 10 2024  9:00AM","SessionId":"596","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Clinical Research 3","ShowChatLink":"false","Start":"4\/10\/2024 9:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Suppression of antigen presentation in pediatric rhabdomyosarcoma","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CL07-07 Translational pediatric cancer research,,"},{"Key":"Keywords","Value":"Rhabdomyosarcoma,ATR,DNA damage response,DNA repair inhibition,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>U. Jo<\/b>, G. Annor, J. Shern; <br\/>NIH-NCI, Bethesda, MD","CSlideId":"","ControlKey":"92b450fe-7bef-46d6-8386-606c1be89e5a","ControlNumber":"9905","DisclosureBlock":"&nbsp;<b>U. Jo, <\/b> None..<br><b>G. Annor, <\/b> None..<br><b>J. Shern, <\/b> None.","End":"4\/10\/2024 12:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"10432","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"5","PosterboardNumber":"5","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB404","PresenterBiography":null,"PresenterDisplayName":"Ukhyun Jo, PhD","PresenterKey":"736e6b88-b3bc-45e0-84d7-8346939364f0","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB404. ATR inhibitors synergize with DHFR inhibitors in rhabdomyosarcoma cells by disrupting DNA damage checkpoint","SearchResultFooter":"","SearchResultHeader":"Apr 10 2024  9:00AM","SessionId":"596","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Clinical Research 3","ShowChatLink":"false","Start":"4\/10\/2024 9:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"ATR inhibitors synergize with DHFR inhibitors in rhabdomyosarcoma cells by disrupting DNA damage checkpoint","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CL08-01 Combination therapy,,"},{"Key":"Keywords","Value":"Androgen receptor,Bipolar androgen therapy (BAT),Nucleotide metabolism,Replication stress,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>S. Jonnatan<\/b><sup>1<\/sup>, R. Kumar<sup>1<\/sup>, V. Vakkala<sup>1<\/sup>, K. Vasan<sup>2<\/sup>, Z. R. Chalmers<sup>2<\/sup>, D. R. Schmidt<sup>3<\/sup>, P. A. Beer<sup>4<\/sup>, M. G. Vander Heiden<sup>3<\/sup>, S. R. Denmeade<sup>1<\/sup>, N. S. Chandel<sup>2<\/sup>, L. A. Sena<sup>1<\/sup>; <br\/><sup>1<\/sup>The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, <sup>2<\/sup>Northwestern University, Feinberg School of Medicine, Chicago, IL, <sup>3<\/sup>Koch Institute, Massachusetts Institute of Technology, Cambridge, MA, <sup>4<\/sup>Step Pharma, Saint-Genis-Pouilly, France","CSlideId":"","ControlKey":"0c0a84ea-ce07-4eba-8091-cab45a9e61a8","ControlNumber":"10406","DisclosureBlock":"&nbsp;<b>S. Jonnatan, <\/b> None..<br><b>R. Kumar, <\/b> None..<br><b>V. Vakkala, <\/b> None..<br><b>K. Vasan, <\/b> None..<br><b>Z. R. Chalmers, <\/b> None..<br><b>D. R. Schmidt, <\/b> None.&nbsp;<br><b>P. A. Beer, <\/b> <br><b>Step Pharma<\/b> Employment.<br><b>M. G. Vander Heiden, <\/b> None..<br><b>S. R. Denmeade, <\/b> None..<br><b>N. S. Chandel, <\/b> None.&nbsp;<br><b>L. A. Sena, <\/b> <br><b>Step Pharma<\/b> Other, Chemical compounds - free of charge. <br><b>Panbela Therapeutics<\/b> Grant\/Contract.","End":"4\/10\/2024 12:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"10433","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"6","PosterboardNumber":"6","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB405","PresenterBiography":null,"PresenterDisplayName":"Sheila Jonnatan, BS","PresenterKey":"be30b8b1-831d-424c-9c98-9fb9ff265fe9","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB405. CTP synthase 1 is a synthetic vulnerability in prostate cancer treated with supraphysiological androgen<b><\/b>","SearchResultFooter":"","SearchResultHeader":"Apr 10 2024  9:00AM","SessionId":"596","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Clinical Research 3","ShowChatLink":"false","Start":"4\/10\/2024 9:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"CTP synthase 1 is a synthetic vulnerability in prostate cancer treated with supraphysiological androgen<b><\/b>","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CL08-01 Combination therapy,,"},{"Key":"Keywords","Value":"Antibody-drug conjugate (ADC),Combination therapy,Ovarian cancer,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>M. Gymnopoulos<\/b><sup>1<\/sup>, R. Tammali<sup>1<\/sup>, A. De Almeida<sup>2<\/sup>, J. Wang<sup>1<\/sup>, C. Myers<sup>1<\/sup>, M. Albertella<sup>3<\/sup>, P. G. Fraenkel<sup>2<\/sup>, P. Sapra<sup>1<\/sup>; <br\/><sup>1<\/sup>AstraZeneca, Gaithersburg, MD, <sup>2<\/sup>AstraZeneca, Waltham, MA, <sup>3<\/sup>AstraZeneca, Cambridge, United Kingdom","CSlideId":"","ControlKey":"20ca40fb-fd0c-42bc-abc6-2573e256b4bd","ControlNumber":"10898","DisclosureBlock":"<b>&nbsp;M. Gymnopoulos, <\/b> <br><b>AstraZeneca<\/b> Employment, Stock Option. <br><b>R. Tammali, <\/b> <br><b>AstraZeneca<\/b> Employment, Stock Option. <br><b>A. De Almeida, <\/b> <br><b>AstraZeneca<\/b> Employment, Stock Option. <br><b>J. Wang, <\/b> <br><b>AstraZeneca<\/b> Employment, Stock Option. <br><b>C. Myers, <\/b> <br><b>AstraZeneca<\/b> Employment, Stock Option. <br><b>M. Albertella, <\/b> <br><b>AstraZeneca<\/b> Employment, Stock Option. <br><b>P. G. Fraenkel, <\/b> <br><b>AstraZeneca<\/b> Employment, Stock Option. <br><b>P. Sapra, <\/b> <br><b>AstraZeneca<\/b> Employment, Stock Option.","End":"4\/10\/2024 12:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"10434","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"7","PosterboardNumber":"7","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB406","PresenterBiography":null,"PresenterDisplayName":"Marco Gymnopoulos, PhD","PresenterKey":"50b9a091-5106-414e-9f1f-fd9a9d0324e6","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB406. Synergistic antitumor effect of FR&#945; TOP1i antibody drug conjugate, AZD5335, in combination with the PARP1 inhibitor, saruparib (AZD5305), in preclinical models of ovarian cancer","SearchResultFooter":"","SearchResultHeader":"Apr 10 2024  9:00AM","SessionId":"596","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Clinical Research 3","ShowChatLink":"false","Start":"4\/10\/2024 9:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Synergistic antitumor effect of FR&#945; TOP1i antibody drug conjugate, AZD5335, in combination with the PARP1 inhibitor, saruparib (AZD5305), in preclinical models of ovarian cancer","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CL08-01 Combination therapy,,"},{"Key":"Keywords","Value":"Sarcoma\/soft-tissue malignancies,Combination therapy,Doxorubicin,Immune response,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>E. B. Dickerson<\/b><sup>1<\/sup>, J. Chacón<sup>2<\/sup>, B. D. Husbands<sup>3<\/sup>, M. S. Henson<sup>1<\/sup>, J. F. Modiano<sup>1<\/sup>, K. M. Stuebner<sup>1<\/sup>, A. Winter<sup>1<\/sup>, S. Pracht<sup>1<\/sup>, A. Chehadeh<sup>1<\/sup>, K. Bergsrud<sup>1<\/sup>, C. Feiock<sup>1<\/sup>, J. Medland<sup>1<\/sup>, H. Scavello<sup>4<\/sup>, P. C. Salah<sup>4<\/sup>, J. Mahoney<sup>5<\/sup>, M. O. Childress<sup>6<\/sup>, D. R. Brown<sup>1<\/sup>, A. Borgatti<sup>1<\/sup>; <br\/><sup>1<\/sup>University of Minnesota, Saint Paul, MN, <sup>2<\/sup>University of Minnesota, Minneapolis, MN, <sup>3<\/sup>The Ohio State University, Columbus, OH, <sup>4<\/sup>University of Pennsylvania, Philadelphia, PA, <sup>5<\/sup>Tufts University, North Grafton, MA, <sup>6<\/sup>Purdue University, West Lafayette, IN","CSlideId":"","ControlKey":"7f20b014-73e5-4b97-93a1-496a2ec20eb3","ControlNumber":"10771","DisclosureBlock":"&nbsp;<b>E. B. Dickerson, <\/b> None..<br><b>J. Chacón, <\/b> None..<br><b>B. D. Husbands, <\/b> None..<br><b>M. S. Henson, <\/b> None.&nbsp;<br><b>J. F. Modiano, <\/b> <br><b>IDEXX Laboratories<\/b> Other, Consulting (KOL). <br><b>Invenra, Inc<\/b> Independent Contractor. <br><b>ImmunityBio, Inc.<\/b> Other, IACUC. <br><b>Anivive Lifesciences, Inc.<\/b> Other, License agreement. <br><b>Companion Biosciences<\/b> Other, Founder.<br><b>K. M. Stuebner, <\/b> None..<br><b>A. Winter, <\/b> None..<br><b>S. Pracht, <\/b> None..<br><b>A. Chehadeh, <\/b> None..<br><b>K. Bergsrud, <\/b> None..<br><b>C. Feiock, <\/b> None..<br><b>J. Medland, <\/b> None..<br><b>H. Scavello, <\/b> None..<br><b>P. C. Salah, <\/b> None..<br><b>J. Mahoney, <\/b> None..<br><b>M. O. Childress, <\/b> None..<br><b>D. R. Brown, <\/b> None.&nbsp;<br><b>A. Borgatti, <\/b> <br><b>Lifengine (Leah Labs)<\/b> Grant\/Contract. <br><b>Calviri<\/b> Grant\/Contract. <br><b>Anivive<\/b> Other, License agreement. <br><b>Merck<\/b> Grant\/Contract.","End":"4\/10\/2024 12:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"10435","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"8","PosterboardNumber":"8","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB407","PresenterBiography":null,"PresenterDisplayName":"Erin Dickerson, PhD","PresenterKey":"9f7357a5-33df-4ce5-9b15-869d7f8ddff7","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB407. Propranolol may enhance long term survivorship in a subset of dogs with hemangiosarcoma when combined with doxorubicin chemotherapy","SearchResultFooter":"","SearchResultHeader":"Apr 10 2024  9:00AM","SessionId":"596","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Clinical Research 3","ShowChatLink":"false","Start":"4\/10\/2024 9:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Propranolol may enhance long term survivorship in a subset of dogs with hemangiosarcoma when combined with doxorubicin chemotherapy","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CL08-02 Molecular targeted therapy,,"},{"Key":"Keywords","Value":"Mismatch repair,Breast cancer,Metastasis,Chemokines,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>T. Tithi<\/b>, J. Mo, W. Zhang; <br\/>University of Florida, Gainesville, FL","CSlideId":"","ControlKey":"d04537a8-36b4-4a8a-b83e-6a8489f6f172","ControlNumber":"10737","DisclosureBlock":"&nbsp;<b>T. Tithi, <\/b> None.&nbsp;<br><b>J. Mo, <\/b> <br><b>Thermofisher<\/b> Employment.<br><b>W. Zhang, <\/b> None.","End":"4\/10\/2024 12:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"10438","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"9","PosterboardNumber":"11","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB410","PresenterBiography":null,"PresenterDisplayName":"Tanzia Islam Tithi","PresenterKey":"8de53d3e-71f2-485a-94db-ffac65c02698","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB410. Contrasting roles of different mismatch repair proteins in basal like breast cancer","SearchResultFooter":"","SearchResultHeader":"Apr 10 2024  9:00AM","SessionId":"596","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Clinical Research 3","ShowChatLink":"false","Start":"4\/10\/2024 9:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Contrasting roles of different mismatch repair proteins in basal like breast cancer","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CL08-02 Molecular targeted therapy,,"},{"Key":"Keywords","Value":"Androgen receptor,Prostate cancer,Class I myosins,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>A. Kadam<\/b>, S. Kumar, V. Vakkala, R. Kumar, A. M. De Marzo, E. J. Pearce, L. A. Sena; <br\/>The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD","CSlideId":"","ControlKey":"f1f9a785-6e34-4f36-8f1d-ab203468ccb7","ControlNumber":"10493","DisclosureBlock":"&nbsp;<b>A. Kadam, <\/b> None..<br><b>S. Kumar, <\/b> None..<br><b>V. Vakkala, <\/b> None..<br><b>R. Kumar, <\/b> None.&nbsp;<br><b>A. M. De Marzo, <\/b> <br><b>Merck<\/b> Other, Paid consultant\/advisor. <br><b>Cepheid<\/b> Other, Paid consultant\/advisor. <br><b>Janssen<\/b> Grant\/Contract. <br><b>Myriad<\/b> Grant\/Contract.<br><b>E. J. Pearce, <\/b> None.&nbsp;<br><b>L. A. Sena, <\/b> <br><b>Panbela Therapeutics<\/b> Grant\/Contract. <br><b>Step Pharma<\/b> Other, Material.","End":"4\/10\/2024 12:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"10439","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"10","PosterboardNumber":"12","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB411","PresenterBiography":null,"PresenterDisplayName":"Anoushka Kadam, BE","PresenterKey":"975b2eba-5d94-4a01-9dc0-60de857b7c4d","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB411. Investigating the dependency of androgen receptor-positive prostate cancer on class I myosins","SearchResultFooter":"","SearchResultHeader":"Apr 10 2024  9:00AM","SessionId":"596","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Clinical Research 3","ShowChatLink":"false","Start":"4\/10\/2024 9:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Investigating the dependency of androgen receptor-positive prostate cancer on class I myosins","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CL08-02 Molecular targeted therapy,,"},{"Key":"Keywords","Value":"Nasopharyngeal carcinoma,Head and neck cancers,Precision medicine,RAF kinase,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"C. Law<sup>1<\/sup>, Z. Liu<sup>1<\/sup>, F. Chan<sup>1<\/sup>, T. Law<sup>2<\/sup>, <b>V. W. Lui<\/b><sup>2<\/sup>; <br\/><sup>1<\/sup>School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong, <sup>2<\/sup>Georgia Cancer Center, and Department of Medicine, Medical College of Georgia, Augusta University, Augusta, GA","CSlideId":"","ControlKey":"c6eaaad9-9cbd-4c9f-9139-ac85a03ea50f","ControlNumber":"10501","DisclosureBlock":"&nbsp;<b>C. Law, <\/b> None..<br><b>Z. Liu, <\/b> None..<br><b>F. Chan, <\/b> None..<br><b>T. Law, <\/b> None..<br><b>V. W. Lui, <\/b> None.","End":"4\/10\/2024 12:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"10440","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"11","PosterboardNumber":"13","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB412","PresenterBiography":null,"PresenterDisplayName":"Vivian Lui, PhD","PresenterKey":"974e7ccd-ddf9-47ca-b1ba-b2816c3743f2","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB412. <i>BRAF<\/i>p.G469E hotspot mutation promotes nasopharyngeal carcinoma tumorigenesis with potential druggability<b><i><\/i><\/b>","SearchResultFooter":"","SearchResultHeader":"Apr 10 2024  9:00AM","SessionId":"596","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Clinical Research 3","ShowChatLink":"false","Start":"4\/10\/2024 9:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"<i>BRAF<\/i>p.G469E hotspot mutation promotes nasopharyngeal carcinoma tumorigenesis with potential druggability<b><i><\/i><\/b>","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CL08-03 Other,,"},{"Key":"Keywords","Value":"Head and neck cancers,Patient-derived xenograft (PDX),Precision medicine,Drug sensitivity,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>Y. Ng<\/b><sup>1<\/sup>, H. Li<sup>2<\/sup>, W. Piao<sup>2<\/sup>, C. Lau<sup>3<\/sup>, P. Poon<sup>2<\/sup>, T. Law<sup>1<\/sup>, J. Chan<sup>4<\/sup>, Y. Su<sup>5<\/sup>, C. Lau<sup>6<\/sup>, Z. Chen<sup>7<\/sup>, L. Ip<sup>2<\/sup>, T.-K. Yeung<sup>2<\/sup>, S. Yeung<sup>2<\/sup>, J.-L. Ngan<sup>2<\/sup>, Z. Liu<sup>1<\/sup>, N. Wiese<sup>8<\/sup>, V. Vo<sup>9<\/sup>, Z. Patel<sup>10<\/sup>, J. Onyekachi<sup>11<\/sup>, L. Afzali<sup>9<\/sup>, J. Afzali<sup>9<\/sup>, J. Smith<sup>12<\/sup>, V. Lui<sup>1<\/sup>; <br\/><sup>1<\/sup>Georgia Cancer Center, Augusta, GA, <sup>2<\/sup>School of Biomedical Sciences, Faculty of Medicine, Shatin, Hong Kong, <sup>3<\/sup>Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, Hong Kong, Hong Kong, <sup>4<\/sup>Department of Otorhinolaryngology, Head and Neck Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong, <sup>5<\/sup>Oral and Maxillofacial Surgery, Faculty of Dentistry, The University of Hong Kong, Hong Kong, Hong Kong, <sup>6<\/sup>Department of Otorhinolaryngology, Yan Chai Hospital, Tsuen Wan, Hong Kong, <sup>7<\/sup>Department of Microbiology, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong, <sup>8<\/sup>Department of Chemistry and Biochemistry, College of Science and Mathematics, Augusta University, Augusta, GA, <sup>9<\/sup>Department of Biology, College of Science and Mathematics, Augusta University, Augusta, GA, <sup>10<\/sup>Medical College of Georgia at Augusta University, Augusta, GA, <sup>11<\/sup>Department of Psychology, College of Science and Mathematics, Augusta University, Augusta, GA, <sup>12<\/sup>Florida Institute of Technology, Melbourne, FL","CSlideId":"","ControlKey":"d2675b73-a3b5-4137-b148-c846348b2a4b","ControlNumber":"10480","DisclosureBlock":"&nbsp;<b>Y. Ng, <\/b> None..<br><b>H. Li, <\/b> None..<br><b>W. Piao, <\/b> None..<br><b>C. Lau, <\/b> None..<br><b>P. Poon, <\/b> None..<br><b>T. Law, <\/b> None..<br><b>J. Chan, <\/b> None..<br><b>Y. Su, <\/b> None..<br><b>C. Lau, <\/b> None..<br><b>Z. Chen, <\/b> None..<br><b>L. Ip, <\/b> None..<br><b>T. Yeung, <\/b> None..<br><b>S. Yeung, <\/b> None..<br><b>J. Ngan, <\/b> None..<br><b>Z. Liu, <\/b> None..<br><b>N. Wiese, <\/b> None..<br><b>V. Vo, <\/b> None..<br><b>Z. Patel, <\/b> None..<br><b>J. Onyekachi, <\/b> None..<br><b>L. Afzali, <\/b> None..<br><b>J. Afzali, <\/b> None..<br><b>J. Smith, <\/b> None..<br><b>V. Lui, <\/b> None.","End":"4\/10\/2024 12:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"10441","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"12","PosterboardNumber":"14","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB413","PresenterBiography":null,"PresenterDisplayName":"Yuen-Keng Ng, BS;M Phil;PhD","PresenterKey":"154b937c-0ce6-43b1-a940-45bd7edee32c","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB413. A newly developed patient-derived culture panel identifies precision therapies and pan-effective agents for head and neck squamous cell carcinoma","SearchResultFooter":"","SearchResultHeader":"Apr 10 2024  9:00AM","SessionId":"596","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Clinical Research 3","ShowChatLink":"false","Start":"4\/10\/2024 9:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"A newly developed patient-derived culture panel identifies precision therapies and pan-effective agents for head and neck squamous cell carcinoma","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CL08-03 Other,,"},{"Key":"Keywords","Value":"Head and neck cancers,ALK,PIK3CA,Patient-derived xenograft (PDX),"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"L. Wang<sup>1<\/sup>, H.-Y. Chan<sup>1<\/sup>, A. Fung<sup>1<\/sup>, Y.-K. Ng<sup>2<\/sup>, P.-S. Ng<sup>3<\/sup>, Y. Su<sup>4<\/sup>, J. Chan<sup>5<\/sup>, P. Poon<sup>1<\/sup>, T. Yeung<sup>1<\/sup>, C. Tsang<sup>6<\/sup>, H.-L. Ngan<sup>1<\/sup>, W. Piao<sup>1<\/sup>, Y. Liu<sup>1<\/sup>, J. Smith<sup>7<\/sup>, T. Law<sup>2<\/sup>, E. Kong<sup>6<\/sup>, M. Chan<sup>8<\/sup>, C. Law<sup>1<\/sup>, S.-M. Chan<sup>1<\/sup>, Z. Liu<sup>1<\/sup>, J.-H. Ng<sup>9<\/sup>, G. B. Mills<sup>10<\/sup>, <b>V. W. Lui<\/b><sup>2<\/sup>; <br\/><sup>1<\/sup>School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong, <sup>2<\/sup>Georgia Cancer Center, Augusta, GA, <sup>3<\/sup>Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, <sup>4<\/sup>Oral and Maxillofacial Surgery, Faculty of Dentistry, The University of Hong Kong, Hong Kong, Hong Kong, <sup>5<\/sup>Department of Otorhinolaryngology, Head and Neck Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong, <sup>6<\/sup>Department of Anatomical and Cellular Pathology, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong, <sup>7<\/sup>Florida Institute of Technology, Melbourne, FL, <sup>8<\/sup>Department of Anatomical and Cellular Pathology, Faculty of Medicine, The Chinese University of Hong Kong,, Shatin, Hong Kong, <sup>9<\/sup>School of Biological Sciences, University of California, San Diego,, San Diego, CA, <sup>10<\/sup>Department of Cell, Developmental and Cancer Biology, Knight Cancer Institute, Oregon Health and Sciences University, Portland, OR","CSlideId":"","ControlKey":"f69080a3-8a67-4506-a1d3-b9a23bb41292","ControlNumber":"10503","DisclosureBlock":"&nbsp;<b>L. Wang, <\/b> None..<br><b>H. Chan, <\/b> None..<br><b>A. Fung, <\/b> None..<br><b>Y. Ng, <\/b> None..<br><b>P. Ng, <\/b> None..<br><b>Y. Su, <\/b> None..<br><b>J. Chan, <\/b> None..<br><b>P. Poon, <\/b> None..<br><b>T. Yeung, <\/b> None..<br><b>C. Tsang, <\/b> None..<br><b>H. Ngan, <\/b> None..<br><b>W. Piao, <\/b> None..<br><b>Y. Liu, <\/b> None..<br><b>J. Smith, <\/b> None..<br><b>T. Law, <\/b> None..<br><b>E. Kong, <\/b> None..<br><b>M. Chan, <\/b> None..<br><b>C. Law, <\/b> None..<br><b>S. Chan, <\/b> None..<br><b>Z. Liu, <\/b> None..<br><b>J. Ng, <\/b> None..<br><b>G. B. Mills, <\/b> None..<br><b>V. W. Lui, <\/b> None.","End":"4\/10\/2024 12:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"10442","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"13","PosterboardNumber":"15","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB414","PresenterBiography":null,"PresenterDisplayName":"Vivian Lui, PhD","PresenterKey":"974e7ccd-ddf9-47ca-b1ba-b2816c3743f2","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB414. Novel <i>ALK\/PIK3CA<\/i> cooperativity in head and neck squamous cell carcinoma (HNSCC) progression","SearchResultFooter":"","SearchResultHeader":"Apr 10 2024  9:00AM","SessionId":"596","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Clinical Research 3","ShowChatLink":"false","Start":"4\/10\/2024 9:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Novel <i>ALK\/PIK3CA<\/i> cooperativity in head and neck squamous cell carcinoma (HNSCC) progression","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CL10-02 Clinical informatics and data science,,"},{"Key":"Keywords","Value":"Chronic myelogenous leukemia,Metabolic syndrome,Risk factors,Statistical approach,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>K. Kim<\/b><sup>1<\/sup>, K. Han<sup>2<\/sup>, S.-E. Lee<sup>1<\/sup>; <br\/><sup>1<\/sup>Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary’s Hospital, College of Medicine, Seoul, Korea, Republic of, <sup>2<\/sup>Department of Statistics and Actuarial Science, Soongsil University, Seoul, Korea, Republic of","CSlideId":"","ControlKey":"f00e605b-fc6e-4cfb-be0c-ae2a6b2382d2","ControlNumber":"10497","DisclosureBlock":"&nbsp;<b>K. Kim, <\/b> None..<br><b>K. Han, <\/b> None..<br><b>S. Lee, <\/b> None.","End":"4\/10\/2024 12:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"10443","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"14","PosterboardNumber":"16","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB415","PresenterBiography":null,"PresenterDisplayName":"Ka Young Kim","PresenterKey":"99543ba7-d4f8-46bb-bd6e-2f3c9779e38f","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB415. Association between waist circumference, body mass index, high-density lipoprotein cholesterol level, and risk of chronic myeloid leukemia","SearchResultFooter":"","SearchResultHeader":"Apr 10 2024  9:00AM","SessionId":"596","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Clinical Research 3","ShowChatLink":"false","Start":"4\/10\/2024 9:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Association between waist circumference, body mass index, high-density lipoprotein cholesterol level, and risk of chronic myeloid leukemia","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CL11-05 Surgical prophylaxis for high risk populations,,"},{"Key":"Keywords","Value":"p53 mutations,Genomics,BRCA,Ovarian cancer,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>C. Coombes<\/b>, B. F. Kohrn, J. U. Fredrickson, E. Latorre-Esteves, E. Hazard, S. Suresh, M. R. Radke, M. Dillon, A. P. Vo, K. Lai, R. Katz, B. M. Norquist, E. M. Swisher, E. U. Parker, R. Risques; <br\/>University of Washington, Seattle, WA","CSlideId":"","ControlKey":"6cb45743-701c-4b74-ada0-5bb2eb5b41b0","ControlNumber":"10894","DisclosureBlock":"&nbsp;<b>C. Coombes, <\/b> None..<br><b>B. F. Kohrn, <\/b> None..<br><b>J. U. Fredrickson, <\/b> None..<br><b>E. Latorre-Esteves, <\/b> None..<br><b>E. Hazard, <\/b> None..<br><b>S. Suresh, <\/b> None..<br><b>M. R. Radke, <\/b> None..<br><b>M. Dillon, <\/b> None..<br><b>A. P. Vo, <\/b> None..<br><b>K. Lai, <\/b> None..<br><b>R. Katz, <\/b> None..<br><b>B. M. Norquist, <\/b> None.&nbsp;<br><b>E. M. Swisher, <\/b> <br><b>Ideaya Biosciences<\/b> Stock Option, Other, Consulting.<br><b>E. U. Parker, <\/b> None.&nbsp;<br><b>R. Risques, <\/b> <br><b>TwinStrand Biosciences Inc.<\/b> Stock, Grant\/Contract, Patent, Other, Consultant. <br><b>NanoString Technologies Inc.<\/b> Stock. <br><b>Ovartec GmbH<\/b> Grant\/Contract, Other.","End":"4\/10\/2024 12:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"10444","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"15","PosterboardNumber":"17","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB416","PresenterBiography":null,"PresenterDisplayName":"CoohleenAnn Coombes, MS","PresenterKey":"cc0f6360-ec3e-4239-81b7-03cb5e49bc98","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB416. Increased<i>TP53<\/i>somatic evolution in the fallopian tubes of individuals at high risk of ovarian cancer","SearchResultFooter":"","SearchResultHeader":"Apr 10 2024  9:00AM","SessionId":"596","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Clinical Research 3","ShowChatLink":"false","Start":"4\/10\/2024 9:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Increased<i>TP53<\/i>somatic evolution in the fallopian tubes of individuals at high risk of ovarian cancer","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CL12-01 Biology of cell and tissue damage,,"},{"Key":"Keywords","Value":"Antibody-drug conjugate (ADC),HER2,Topoisomerase I inhibitor,Senescence,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"I. Lua<sup>1<\/sup>, L. Jia<sup>1<\/sup>, J. Chen<sup>1<\/sup>, K. Contrepois<sup>1<\/sup>, M. McFarlane<sup>2<\/sup>, A. I. Rosenbaum<sup>1<\/sup>, P. Newham<sup>2<\/sup>, <b>S. Terrillon<\/b><sup>1<\/sup>; <br\/><sup>1<\/sup>AstraZeneca, South San Francisco, CA, <sup>2<\/sup>AstraZeneca, Cambridge, United Kingdom","CSlideId":"","ControlKey":"e83fa0f0-67a9-4b1f-a39f-6b06ce05f4e3","ControlNumber":"9660","DisclosureBlock":"<b>&nbsp;I. Lua, <\/b> <br><b>AstraZeneca<\/b> Employment, Stock. <br><b>L. Jia, <\/b> <br><b>AstraZeneca<\/b> Employment, Stock. <br><b>J. Chen, <\/b> <br><b>AstraZeneca<\/b> Employment, Stock. <br><b>K. Contrepois, <\/b> <br><b>AstraZeneca<\/b> Employment, Stock. <br><b>M. McFarlane, <\/b> <br><b>AstraZeneca<\/b> Employment, Stock. <br><b>A. I. Rosenbaum, <\/b> <br><b>AstraZeneca<\/b> Employment, Stock. <br><b>P. Newham, <\/b> <br><b>AstraZeneca<\/b> Employment, Stock. <br><b>S. Terrillon, <\/b> <br><b>AstraZeneca<\/b> Employment, Stock.","End":"4\/10\/2024 12:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"10445","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"16","PosterboardNumber":"18","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB417","PresenterBiography":null,"PresenterDisplayName":"Sonia Terrillon, PhD","PresenterKey":"28b3b505-b4a7-4097-b050-dea4bc5e4aa9","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB417. Leveraging advanced human lung models to explore mechanisms underlying T-DXd-associated interstitial lung disease (ILD)","SearchResultFooter":"","SearchResultHeader":"Apr 10 2024  9:00AM","SessionId":"596","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Clinical Research 3","ShowChatLink":"false","Start":"4\/10\/2024 9:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Leveraging advanced human lung models to explore mechanisms underlying T-DXd-associated interstitial lung disease (ILD)","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CL12-08 Other,,"},{"Key":"Keywords","Value":"Adjuvant,Breast cancer,Survival,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>A. G. Deboch<\/b>; <br\/>Adwa Partners Consultancy, Addis Ababa, Ethiopia","CSlideId":"","ControlKey":"ccb521eb-29fe-4f90-bdd7-95010af7c308","ControlNumber":"10281","DisclosureBlock":"&nbsp;<b>A. G. Deboch, <\/b> None.","End":"4\/10\/2024 12:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"10446","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"17","PosterboardNumber":"19","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB418","PresenterBiography":null,"PresenterDisplayName":"Adugna Deboch, MD","PresenterKey":"c58db1bc-b6ce-48fc-b24d-c3a4268af8e7","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB418. Time to adjuvant chemotherapy and its predictors among postoperative breast cancer patients at Cancer Treatment Center of Hawassa University Comprehensive Specialized Hospital in Hawassa, Ethiopia in 2022: A retrospective follow-up study","SearchResultFooter":"","SearchResultHeader":"Apr 10 2024  9:00AM","SessionId":"596","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Clinical Research 3","ShowChatLink":"false","Start":"4\/10\/2024 9:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Time to adjuvant chemotherapy and its predictors among postoperative breast cancer patients at Cancer Treatment Center of Hawassa University Comprehensive Specialized Hospital in Hawassa, Ethiopia in 2022: A retrospective follow-up study","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CL13-01 Clinical imaging,,"},{"Key":"Keywords","Value":"Aromatase,neuroinflammation,chronic pain,translocator protein (18kDa),"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>Y. Zhu<\/b><sup>1<\/sup>, N. Swanson<sup>2<\/sup>, J. Murphy<sup>2<\/sup>, M. Kim<sup>2<\/sup>, A. Partridge<sup>3<\/sup>, R. Edwards<sup>4<\/sup>, K. Schreiber<sup>4<\/sup>, M. Loggia<sup>1<\/sup>; <br\/><sup>1<\/sup>Massachusetts General Hospital, Harvard Medical School, Boston, MA, <sup>2<\/sup>Massachusetts General Hospital, Boston, MA, <sup>3<\/sup>Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, <sup>4<\/sup>Brigham and Women’s Hospital, Harvard Medical School, Boston, MA","CSlideId":"","ControlKey":"35866360-c62c-4086-b8a7-04ac14905a2b","ControlNumber":"10689","DisclosureBlock":"&nbsp;<b>Y. Zhu, <\/b> None..<br><b>N. Swanson, <\/b> None..<br><b>J. Murphy, <\/b> None..<br><b>M. Kim, <\/b> None..<br><b>A. Partridge, <\/b> None..<br><b>R. Edwards, <\/b> None..<br><b>K. Schreiber, <\/b> None..<br><b>M. Loggia, <\/b> None.","End":"4\/10\/2024 12:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"10447","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"18","PosterboardNumber":"20","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB419","PresenterBiography":null,"PresenterDisplayName":"Yehui Zhu, PhD","PresenterKey":"0c92958d-9ef5-4163-9916-f38734b5228a","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB419. Neuroinflammation and aromatase inhibitor associated musculoskeletal syndrome (AIMSS) in breast cancer: Initial insights from [<sup>11<\/sup>C]PBR28 PET\/MR imaging","SearchResultFooter":"","SearchResultHeader":"Apr 10 2024  9:00AM","SessionId":"596","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Clinical Research 3","ShowChatLink":"false","Start":"4\/10\/2024 9:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Neuroinflammation and aromatase inhibitor associated musculoskeletal syndrome (AIMSS) in breast cancer: Initial insights from [<sup>11<\/sup>C]PBR28 PET\/MR imaging","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CL13-03 Epigenetic therapy,,"},{"Key":"Keywords","Value":"HDAC inhibitor,PARP inhibitors,Cell cycle checkpoints,Ovarian cancer,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>V. G. Gupta<\/b><sup>1<\/sup>, H. Liu<sup>2<\/sup>, R. Zhang<sup>3<\/sup>, M. Onken<sup>1<\/sup>, A. Wilson<sup>4<\/sup>, F. Yull<sup>4<\/sup>, M. Crispens<sup>4<\/sup>, M. Mullen<sup>1<\/sup>, D. Khabele<sup>1<\/sup>; <br\/><sup>1<\/sup>University of Washington, School of Medicine, St. Louis, MO, <sup>2<\/sup>Wistar Institute, Philadelphia, PA, <sup>3<\/sup>The University of Texas MD Anderson Cancer Center, Houston, TX, <sup>4<\/sup>Vanderbilt University, Nashville, TN","CSlideId":"","ControlKey":"e1f7c6c0-305f-4042-b151-06dc6211479c","ControlNumber":"10716","DisclosureBlock":"&nbsp;<b>V. G. Gupta, <\/b> None..<br><b>H. Liu, <\/b> None..<br><b>R. Zhang, <\/b> None..<br><b>M. Onken, <\/b> None..<br><b>A. Wilson, <\/b> None..<br><b>F. Yull, <\/b> None.&nbsp;<br><b>M. Crispens, <\/b> <br><b>Astra Zeneca<\/b> Grant\/Contract.<br><b>M. Mullen, <\/b> None.&nbsp;<br><b>D. Khabele, <\/b> <br><b>Astra Zeneca<\/b> Grant\/Contract. <br><b>Deciphera pharmaceuticals<\/b> Grant\/Contract.","End":"4\/10\/2024 12:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"10449","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"19","PosterboardNumber":"22","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB421","PresenterBiography":null,"PresenterDisplayName":"Vijayalaxmi Gupta, PhD","PresenterKey":"fd5b3830-5605-4948-a939-939e715f6b51","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB421. Entinostat alters cell cycle in ovarian cancer cells","SearchResultFooter":"","SearchResultHeader":"Apr 10 2024  9:00AM","SessionId":"596","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Clinical Research 3","ShowChatLink":"false","Start":"4\/10\/2024 9:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Entinostat alters cell cycle in ovarian cancer cells","Topics":null,"cSlideId":""},{"Abstract":"Abstract is embargoed at this time.","Actions":[{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Late Breaking and Clinical Trials","AdditionalFields":[{"Key":"Topics","Value":"++CL13-05 Molecular classification of tumors,,"},{"Key":"Keywords","Value":"Lymphoma,DNA methylation,Epstein-Barr virus (EBV),Brain\/central nervous system cancers,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":null,"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<b>C. Weigel<\/b><sup>1<\/sup>, H. L. Klimaszewski<sup>2<\/sup>, S. Addissie<sup>3<\/sup>, S. Schlotter<sup>2<\/sup>, F. Tounkara<sup>4<\/sup>, J. P. Dugan<sup>5<\/sup>, B. M. Haverkos<sup>6<\/sup>, L. Villagomez<sup>7<\/sup>, M. Lustberg<sup>8<\/sup>, P. Porcu<sup>9<\/sup>, T. Voorhees<sup>10<\/sup>, M. A. Caligiuri<sup>11<\/sup>, G. Bumgardner<sup>12<\/sup>, C. C. Oakes<sup>1<\/sup>, R. Baiocchi<sup>1<\/sup>; <br\/><sup>1<\/sup>Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, <sup>2<\/sup>College of Medicine, The Ohio State University, Columbus, OH, <sup>3<\/sup>Department of Internal Medicine, Johns Hopkins University, Baltimore, MD, <sup>4<\/sup>Center for Biostatistics, The Ohio State University, Columbus, OH, <sup>5<\/sup>Malignant Hematology and Cellular Therapy Department, Novant Health Cancer Institute - Forsyth Medical Center, Winston-Salem, NC, <sup>6<\/sup>Division of Hematology, University of Colorado School of Medicine, Aurora, CO, <sup>7<\/sup>Department of Pediatrics, Division of Hematology and Oncology, The Ohio State University and Nationwide Children's Hospital, Columbus, OH, <sup>8<\/sup>Division of Infectious Disease, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, <sup>9<\/sup>Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, <sup>10<\/sup>Department of Hematology, James Comprehensive Cancer Center, The Ohio State University, Columbus, OH, <sup>11<\/sup>Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA, <sup>12<\/sup>Comprehensive Transplant Center, Department of Surgery, The Ohio State University College of Medicine, Columbus, OH","CSlideId":"","ControlKey":"c28da138-5602-490b-a3c4-eda88c84452a","ControlNumber":"10454","DisclosureBlock":"&nbsp;<b>C. Weigel, <\/b> None..<br><b>H. L. Klimaszewski, <\/b> None..<br><b>S. Addissie, <\/b> None..<br><b>S. Schlotter, <\/b> None..<br><b>F. Tounkara, <\/b> None..<br><b>J. P. Dugan, <\/b> None..<br><b>B. M. Haverkos, <\/b> None..<br><b>L. Villagomez, <\/b> None..<br><b>M. Lustberg, <\/b> None..<br><b>P. Porcu, <\/b> None..<br><b>T. Voorhees, <\/b> None..<br><b>M. A. Caligiuri, <\/b> None..<br><b>G. Bumgardner, <\/b> None..<br><b>C. C. Oakes, <\/b> None..<br><b>R. Baiocchi, <\/b> None.","End":"4\/10\/2024 12:30:00 PM","HasWebcast":null,"Highlights":[],"Id":"10450","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":null,"OtherContent":null,"PlayerUrl":"https:\/\/files.abstractsonline.com\/SUPT\/101\/10517\/cfg-cattendee-cslide-player-view-content-embargoed.png","PlayerUrlReason":"Content is embargoed at this time.","PositionInSession":"20","PosterboardNumber":"23","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"LB422","PresenterBiography":null,"PresenterDisplayName":"Christoph Weigel, PhD","PresenterKey":"fc159185-a72b-41cd-9257-5b579c1a0dc1","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"LB422. Specific activation of the Epstein-Barr Virus <i>BGLF4<\/i> locus via lowered DNA methylation in EBV-associated CNS lymphoproliferative disease","SearchResultFooter":"","SearchResultHeader":"Apr 10 2024  9:00AM","SessionId":"596","SessionOnDemand":"False","SessionTitle":"Late-Breaking Research: Clinical Research 3","ShowChatLink":"false","Start":"4\/10\/2024 9:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Specific activation of the Epstein-Barr Virus <i>BGLF4<\/i> locus via lowered DNA methylation in EBV-associated CNS lymphoproliferative disease","Topics":null,"cSlideId":""}]